Filana Therapeutics, Inc. SEC filings FLNA
Filana Therapeutics, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Nov 9, 2006. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 14, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 3, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Mar 22, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 28, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Mar 16, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 28, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 1, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 23, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 26, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 29, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Feb 6, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 7, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Mar 3, 2016 | Dec 31, 2015 |
| 10-K | Annual report | Feb 18, 2015 | Dec 31, 2014 |
| 10-K | Annual report | Feb 5, 2014 | Dec 31, 2013 |
| 10-K | Annual report | Feb 8, 2013 | Dec 31, 2012 |
| 10-K/A | Amended annual report | May 9, 2012 | Dec 31, 2005 |
| 10-K | Annual report | Feb 9, 2012 | Dec 31, 2011 |
| 10-K | Annual report | Feb 3, 2011 | Dec 31, 2010 |
| 10-K | Annual report | Feb 1, 2010 | Dec 31, 2009 |
| 10-K | Annual report | Feb 13, 2009 | Dec 31, 2008 |
| 10-K | Annual report | Feb 13, 2008 | Dec 31, 2007 |
| 10-K | Annual report | Feb 26, 2007 | Dec 31, 2006 |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- FLNA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Austin, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1069530
- Former names
- CASSAVA SCIENCES INC (until Feb 19, 2026); PAIN THERAPEUTICS INC (until Mar 25, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.